People who use Reglan may be at risk to tardive dyskinesia. Recently published analyses suggest that Reglan, also known as metoclopramide, is the most common cause of drug-induced movement disorders. More than two million Americans use these products for the treatment of a number of gastrointestinal disorders depending on what form the physician prescribes the medication. The FDA has become aware of continued spontaneous reports of tardive dyskinesia in patients who used metoclopramide, the majority of whom had taken the drug for more than three months.

To find out more, please visit: Tardive Dyskinesia Lawsuits.